292 related articles for article (PubMed ID: 9632036)
1. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
[TBL] [Abstract][Full Text] [Related]
2. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
[TBL] [Abstract][Full Text] [Related]
3. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
4. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
Elliott AJ; Russo J; Bergam K; Claypoole K; Uldall KK; Roy-Byrne PP
J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
[TBL] [Abstract][Full Text] [Related]
7. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
Saiz-Ruiz J; Ibañez A; Díaz-Marsá M; Arias F; Carrasco JL; Huertas D; Martín-Carrasco M; Moreno I; Rico-Villademoros F
CNS Drugs; 2002; 16(9):635-43. PubMed ID: 12153334
[TBL] [Abstract][Full Text] [Related]
8. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
Thase ME
J Clin Psychiatry; 1997 Sep; 58(9):393-8. PubMed ID: 9378690
[TBL] [Abstract][Full Text] [Related]
10. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Marcus RN; Mendels J
J Clin Psychiatry; 1996; 57 Suppl 2():19-23. PubMed ID: 8626359
[TBL] [Abstract][Full Text] [Related]
11. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
[TBL] [Abstract][Full Text] [Related]
12. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
[TBL] [Abstract][Full Text] [Related]
13. Which depressed patients respond to nefazodone and when?
Trivedi MH; Rush AJ; Pan JY; Carmody TJ
J Clin Psychiatry; 2001 Mar; 62(3):158-63. PubMed ID: 11305700
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
Feiger AD; Bielski RJ; Bremner J; Heiser JF; Trivedi M; Wilcox CS; Roberts DL; Kensler TT; McQuade RD; Kaplita SB; Archibald DG
Int Clin Psychopharmacol; 1999 Jan; 14(1):19-28. PubMed ID: 10221638
[TBL] [Abstract][Full Text] [Related]
15. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
Roy-Byrne PP; Pages KP; Russo JE; Jaffe C; Blume AW; Kingsley E; Cowley DS; Ries RK
J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
17. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Gelenberg AJ; Trivedi MH; Rush AJ; Thase ME; Howland R; Klein DN; Kornstein SG; Dunner DL; Markowitz JC; Hirschfeld RM; Keitner GI; Zajecka J; Kocsis JH; Russell JM; Miller I; Manber R; Arnow B; Rothbaum B; Munsaka M; Banks P; Borian FE; Keller MB
Biol Psychiatry; 2003 Oct; 54(8):806-17. PubMed ID: 14550680
[TBL] [Abstract][Full Text] [Related]
18. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
Feighner JP; Overø K
J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
[TBL] [Abstract][Full Text] [Related]
19. Nefazodone: aspects of efficacy.
Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
[TBL] [Abstract][Full Text] [Related]
20. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I
J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]